Wintrust Investments’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$111K Sell
370
-19
-5% -$6.64K 0.1% 155
2024
Q3
$158K Sell
389
-3,285
-89% -$1.2M 0.12% 152
2024
Q2
$1.18M Buy
3,674
+39
+1% +$12.7K 0.1% 177
2024
Q1
$1.21M Buy
3,635
+115
+3% +$35.1K 0.11% 169
2023
Q4
$953K Buy
3,520
+770
+28% +$190K 0.09% 178
2023
Q3
$677K Buy
2,750
+199
+8% +$54.5K 0.07% 224
2023
Q2
$774K Buy
+2,551
New +$709K 0.08% 206
2021
Q3
Sell
-1,950
Closed -$220K 337
2021
Q2
$220K Buy
+1,950
New +$397K 0.02% 394

Other funds holding HCA

Wintrust Investments's HCA Position: Q4 2024 in Review

Wintrust Investments reduced its HCA Healthcare (HCA) stake by 4.9% in Q4 2024, selling an estimated $6.64K and leaving 370 shares worth $111K. The position accounts for 0.1% of the portfolio, ranked #155.

Wintrust Investments first reported a position in HCA in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.21M in Q1 2024. 1,181 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Wintrust Investments held 370 shares of HCA Healthcare worth $111K as of Q4 2024.
  • Wintrust Investments sold 19 HCA Healthcare shares in Q4 2024, an estimated $6.64K.
  • HCA Healthcare made up 0.1% of Wintrust Investments's portfolio in Q4 2024, its #155 holding.
  • Wintrust Investments first reported a position in HCA Healthcare in Q2 2021 and has held it in 8 quarters since.
  • Wintrust Investments's HCA Healthcare position peaked at $1.21M in Q1 2024.
  • 1,181 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.